Why the study?
Does pericardioscopy-guided extensive sampling improve the diagnostic value and efficiency of pericardial biopsy compared to fluoroscopy-guided standard sampling in patients with large pericardial effusion?
Does pericardioscopy-guided extensive sampling improve the diagnostic value and efficiency of pericardial biopsy compared to fluoroscopy-guided standard sampling in patients with large pericardial effusion?
Pericardioscopy-guided extensive sampling significantly improves the diagnostic yield and reduces false-negative rates of pericardial biopsy compared to standard fluoroscopic guidance.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for pericardioscopy-guided pericardial biopsy; prospective trials needed before clinical adoption.
BACKGROUND: The clinical significance of pericardial biopsy is controversial. The aim of this study was to assess the feasibility and diagnostic value of 3 approaches to pericardial biopsy: fluoroscopic control and standard sampling, pericardioscopy guidance with standard sampling, and pericardioscopy guidance with extensive sampling. METHODS AND RESULTS: Forty-nine subsequent patients with a large pericardial effusion underwent parietal pericardial biopsy. In group 1 (12 patients, 66.7% males, age 46.7+/-12.2 years), pericardial biopsy was guided by fluoroscopy (3 to 6 samples per patient). Group 2 included 22 patients (50% males, age 50.8+/-10.4 years) undergoing 4 to 6 pericardial biopsies per patient guided by pericardioscopy (16F flexible endoscope). In group 3, extensive pericardial sampling was performed, guided by pericardioscopy (15 patients, 53.3% males, age 53.7+/-12.8 years, 18 to 20 samples per patient). Sampling efficiency was better with pericardioscopy (group 2, 84.9%; group 3, 84.2%) compared with fluoroscopic guidance (group 1, 43.7%; P<0.01). Diagnostic value was defined as a new diagnosis uncovered, etiology revealed, clinical diagnosis confirmed, and the biopsy false-negative. Pericardial biopsy in group 3 had higher diagnostic value than in group 1 in revealing new diagnosis (40% versus 8.3%, P<0.05) and etiology (53.3% versus 8.3%, P<0.05). In group 2, pericardial biopsy had a higher yield in establishing etiology than in group 1 (40.9% versus 8.3%; P<0.05). Pericardial biopsy was false-negative in 58.3% in group 1 in contrast to 6.7% in group 3 (P<0.01). There were no major complications. CONCLUSIONS: Pericardioscopic guidance enhanced pericardial sampling efficiency. The diagnostic value of pericardial biopsy was significantly improved by extensive sampling made possible by pericardioscopy.
No takes yet. Share an insight, caveat, or question.
Seferović et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: